SS
GLUE icon

Sunbelt Securities’s Monte Rosa Therapeutics GLUE Stock Holding History

Sunbelt Securities’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Hold
1
– – ﹤0.01% 2892
2025
Q4 		$16 Buy
+1
New +$13 ﹤0.01% 2741

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Sunbelt Securities's GLUE Position: Q1 2026 in Review

Sunbelt Securities held its Monte Rosa Therapeutics (GLUE) position steady in Q1 2026 at 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Sunbelt Securities first reported a position in GLUE in Q4 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • Sunbelt Securities held 1 share of Monte Rosa Therapeutics worth $16 as of Q1 2026.
  • Sunbelt Securities left its Monte Rosa Therapeutics share count unchanged in Q1 2026.
  • Monte Rosa Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2892 holding.
  • Sunbelt Securities first reported a position in Monte Rosa Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.